Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose and Parallel Arm Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-830216 (Prodrug of BMS-819881) in Obese Subjects.
Phase of Trial: Phase I/II
Latest Information Update: 06 Nov 2015
At a glance
- Drugs BMS 830216 (Primary)
- Indications Obesity
- Focus Adverse reactions
- 06 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Jun 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 10 May 2011 Planned End Date changed from 1 May 2011 to 1 Jun 2011 as reported by ClinicalTrials.gov.